blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2068838

EP2068838 - PHARMACEUTICAL FORMULATIONS COMPRISING CLOPIDOGREL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.02.2013
Database last updated on 23.04.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Acino Pharma AG
Birsweg 2
4253 Liesberg / CH
[2012/09]
Former [2009/25]For all designated states
Acino Pharma AG
Erlenstrasse 1
4058 Basel / CH
Inventor(s)01 / REY, Hélène
1, Impasse des Peupliers
FR-68128 Rosenau / FR
02 / FISCHER, Marc
Blumenstrasse 19
CH-4106 Therwil / CH
03 / SCHEER, Mathias
Mozartstr. 9
79664 Wehr / DE
 [2009/25]
Representative(s)Henkel & Partner mbB
Patentanwaltskanzlei, Rechtsanwaltskanzlei
Erika-Mann Strasse 23
80636 München / DE
[N/P]
Former [2011/44]Henkel, Breuer & Partner
Patentanwälte
Erika-Mann Strasse 23
80636 München / DE
Former [2011/19]Breuer, Markus
Breuer & Müller Partnerschaft Patentanwälte Heimeranstrasse 35
80339 München / DE
Former [2009/31]Braun, André jr., et al
Braunpat Braun Eder AG Reussstrasse 22 Postfach
4015 Basel / CH
Former [2009/25]Braun, André jr., et al
Braunpat Braun Eder AG Reussstrasse 22
4054 Basel / CH
Application number, filing date07818184.917.09.2007
[2009/25]
WO2007EP08070
Priority number, dateEP2006001942916.09.2006         Original published format: EP 06019429
[2009/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008031623
Date:20.03.2008
Language:EN
[2008/12]
Type: A1 Application with search report 
No.:EP2068838
Date:17.06.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 20.03.2008 takes the place of the publication of the European patent application.
[2009/25]
Type: B1 Patent specification 
No.:EP2068838
Date:11.04.2012
Language:EN
[2012/15]
Search report(s)International search report - published on:EP20.03.2008
ClassificationIPC:A61K9/16, A61K9/20, A61K31/60
[2009/25]
CPC:
A61K9/1641 (EP,US); A61K9/1617 (EP,US); A61K9/1694 (EP,US);
A61K9/2077 (EP,US); A61P9/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/25]
TitleGerman:PHARMAZEUTISCHE FORMULIERUNGEN MIT CLOPIDOGREL[2009/25]
English:PHARMACEUTICAL FORMULATIONS COMPRISING CLOPIDOGREL[2009/25]
French:FORMULATIONS PHARMACEUTIQUES CONTENANT DU CLOPIDOGREL[2009/25]
Entry into regional phase16.04.2009National basic fee paid 
16.04.2009Designation fee(s) paid 
16.04.2009Examination fee paid 
Examination procedure16.04.2009Examination requested  [2009/25]
03.08.2009Despatch of a communication from the examining division (Time limit: M04)
24.10.2009Reply to a communication from the examining division
03.05.2010Observations by third parties
24.11.2010Observations by third parties
12.09.2011Cancellation of oral proceeding that was planned for 13.10.2011
13.10.2011Date of oral proceedings (cancelled)
24.10.2011Communication of intention to grant the patent
23.02.2012Fee for grant paid
23.02.2012Fee for publishing/printing paid
Divisional application(s)EP11003617.5  / EP2359810
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.08.2009
Opposition(s)14.01.2013No opposition filed within time limit [2013/12]
Fees paidRenewal fee
30.09.2009Renewal fee patent year 03
30.09.2010Renewal fee patent year 04
26.09.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.09.2007
CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
MT11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
TR11.04.2012
BG11.07.2012
IS11.08.2012
AT17.09.2012
IE17.09.2012
IT17.09.2012
LU17.09.2012
PL17.09.2012
ES18.09.2012
BE30.09.2012
MC30.09.2012
[2014/34]
Former [2014/27]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
MT11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
TR11.04.2012
BG11.07.2012
IS11.08.2012
AT17.09.2012
IE17.09.2012
IT17.09.2012
LU17.09.2012
PL17.09.2012
ES18.09.2012
BE30.09.2012
MC30.09.2012
Former [2014/26]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
MT11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
TR11.04.2012
BG11.07.2012
IS11.08.2012
AT17.09.2012
IE17.09.2012
IT17.09.2012
PL17.09.2012
ES18.09.2012
BE30.09.2012
MC30.09.2012
Former [2014/21]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
MT11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
TR11.04.2012
BG11.07.2012
IS11.08.2012
AT17.09.2012
IE17.09.2012
IT17.09.2012
PL17.09.2012
BE30.09.2012
MC30.09.2012
Former [2014/09]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
MT11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
BG11.07.2012
IS11.08.2012
AT17.09.2012
IE17.09.2012
IT17.09.2012
PL17.09.2012
BE30.09.2012
MC30.09.2012
Former [2013/51]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
MT11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
BG11.07.2012
IS11.08.2012
IE17.09.2012
IT17.09.2012
PL17.09.2012
BE30.09.2012
MC30.09.2012
Former [2013/50]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
BG11.07.2012
IS11.08.2012
IE17.09.2012
IT17.09.2012
PL17.09.2012
BE30.09.2012
MC30.09.2012
Former [2013/37]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
BG11.07.2012
IS11.08.2012
IE17.09.2012
IT17.09.2012
BE30.09.2012
MC30.09.2012
Former [2013/34]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
BG11.07.2012
IS11.08.2012
IE17.09.2012
BE30.09.2012
MC30.09.2012
Former [2013/33]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
IS11.08.2012
IE17.09.2012
BE30.09.2012
MC30.09.2012
Former [2013/20]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
IS11.08.2012
MC30.09.2012
Former [2013/10]CY11.04.2012
CZ11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
RO11.04.2012
SI11.04.2012
SK11.04.2012
IS11.08.2012
Former [2013/09]CY11.04.2012
EE11.04.2012
LT11.04.2012
LV11.04.2012
SI11.04.2012
IS11.08.2012
Former [2012/51]CY11.04.2012
LT11.04.2012
LV11.04.2012
SI11.04.2012
IS11.08.2012
Former [2012/50]CY11.04.2012
LT11.04.2012
LV11.04.2012
IS11.08.2012
Former [2012/49]CY11.04.2012
LT11.04.2012
IS11.08.2012
Former [2012/47]LT11.04.2012
Cited inInternational search[DY]US4847265  (BADORC ALAIN [FR], et al) [DY] 1-3* column 1, line 45 - line 50 *;
 JPH0789875  [ ] (DAIICHI SEIYAKU CO);
 [XY]FR2792836  (SANOFI SA [FR]) [X] 1,2,4-17 * page 2, line 5 - line 14 * * page 3, line 5 - line 19 * * examples 10,11 * * claim - * [Y] 1-17;
 [XY]EP1161956  (DAIICHI SEIYAKU CO [JP]) [X] 1,2,6,8-17 * paragraph [0007] - paragraph [0008] * * examples 3,4 * * claim - * [Y] 1-17;
 [Y]WO2004072085  (HELM AG [DE], et al) [Y] 1-3 * example 4 *;
 [XY]  - MATSUMOTO, TAKAHIRO ET AL, "Pharmaceutical tablets prevented from delayed disintegration", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 123:17941, URL: STN, XP002421170 [X] 1,2,4-17 * abstract * [Y] 1-17
ExaminationEP1900358
otherEP1900358
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.